Macquarie Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,987
Closed -$182K 2522
2022
Q2
$182K Sell
3,987
-3,785
-49% -$169K ﹤0.01% 1734
2022
Q1
$361 Buy
+7,772
New +$348K ﹤0.01% 1722
2017
Q4
Sell
-2,000
Closed -$75K 2412
2017
Q3
$75K Buy
+2,000
New +$68.1K ﹤0.01% 1963
2016
Q2
Sell
-2,899
Closed -$45K 1618
2016
Q1
$45K Buy
+2,899
New +$41.6K ﹤0.01% 1476

Other funds holding LMAT

Macquarie Group's LMAT Position: Q3 2022 in Review

Macquarie Group sold out of LeMaitre Vascular (LMAT) in Q3 2022, closing a stake of 3,987 shares — an estimated $182K sold.

Macquarie Group first reported a position in LMAT in Q1 2016 and held it in 4 quarters. The position peaked at $182K in Q2 2022. 189 funds tracked by Wall St. Rank hold LMAT as of Q3 2022.

  • Macquarie Group reported no remaining LeMaitre Vascular position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 3,987 LeMaitre Vascular shares in Q3 2022, an estimated $182K.
  • Macquarie Group first reported a position in LeMaitre Vascular in Q1 2016 and held it in 4 quarters.
  • Macquarie Group's LeMaitre Vascular position peaked at $182K in Q2 2022.
  • 189 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.